Astrazeneca reported $35.13B in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
AstraZeneca AZN:LN USD 35.13B 798M
Astrazeneca AZN:US USD 35.13B 798M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Canopy Growth Corp WEED:CN CAD 1.68B 9.07M
Catalent CTLT:US USD 4.7B 95M
Corcept Therapeutics CORT:US USD 473.36M 31.04M
Drreddys Laboratories RDY:US INR 220.27B 14.05B
Eli Lilly And LLY:US USD 10.07B 1.53B
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Genmab GEN:DC DKK 26.66B 2.18B
Horizon Pharma HZNP:US USD 5.03B 88.16M
Lannett LCI:US USD -277561000 26.5M
Merk MRK:US USD 44.46B 1.22B
Novartis NOVN:VX USD 60.82B 2.1B
Pacira Pharmaceuticals PCRX:US USD 770.12M 13.49M
Perrigo Ordinary Shares PRGO:US USD 4.6B 247.1M
Phibro Animal Health PAHC:US USD 262.76M 314K
Prestige Brands PBH:US USD 1.62B 35.1M
Roche Holding ROG:VX 25.19B 700M
Supernus Pharmaceuticals SUPN:US USD 852.8M 11.36M
Teva Pharmaceutical Industries TEVA:US USD 8.77B 269M
Valeant Pharmaceuticals VRX:CN USD -525000000 168M
Zoetis ZTS:US USD 4.66B 83M